% | $
Quotes you view appear here for quick access.

Puma Biotechnology, Inc. Message Board

  • gregbruno90 gregbruno90 Aug 8, 2014 9:12 AM Flag

    Secondary - they will not announce anything about a Secondary until last 2 trials are announced...

    This company is sold before a secondary is needed. You must know company; they are not set up to manufacture. They only know how to set up trials and design them to get data approved. This is not a manufacturing company. It is sold way before secondary is needed. This is phase 3 data so FDA probably doesn't request additional Trials. FDA can approve based upon precendants...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • So at $400/share you're saying that some company is going to pay $13-14 billion for this company based on one drug that needs to be used in combination with another drug that they don't own, and that they only have a license to use from Pfizer? Cougar was sold for $1 billion, but that is 1/7 of Puma's present valuation. As Jack Nicholson said in A Few Good Men, "tell me you have more."

76.90+0.20(+0.26%)Oct 2 4:02 PMEDT